{"transactions":[{"id":690480,"issuer":{"id":7510,"kind":"organization","name":"FEMASYS INC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-12T01:02:13.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option vest one year from the date of grant, assuming continued service."}],"balance_after":880,"derivative":{"exercise_price":3.67,"expiration_date":"2036-06-24","underlying":"Common Stock","underlying_shares":880},"source":{"system":"sec-edgar","filing":"0001140361-26-032345","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339005/000114036126032345/form4.xml","form_type":"4"}},{"id":945559,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-01-07T01:00:35.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option shall vest with respect to one-fourth (1/4) of the total number of shares underlying the option on January 2, 2027 and the remaining shares in 36 equal monthly installments thereafter."}],"balance_after":100000,"derivative":{"exercise_price":7.08,"expiration_date":"2036-01-02","underlying":"Ordinary Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001901321-26-000002","document":"form4-01062026_080121.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000190132126000002/form4-01062026_080121.xml","form_type":"4"}},{"id":945558,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-01-07T01:00:35.000Z","date":"2026-01-05","kind":"sale","planned":false,"acquired":false,"shares":3416,"price":6.46,"value":22067.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.30 to $6.70 inclusive."}],"balance_after":136717,"source":{"system":"sec-edgar","filing":"0001901321-26-000002","document":"form4-01062026_080121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000190132126000002/form4-01062026_080121.xml","form_type":"4"}},{"id":945557,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-01-07T01:00:35.000Z","date":"2026-01-02","kind":"sale","planned":false,"acquired":false,"shares":3244,"price":6.8,"value":22059.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.62 to $7.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) and (5)."}],"balance_after":140133,"source":{"system":"sec-edgar","filing":"0001901321-26-000002","document":"form4-01062026_080121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000190132126000002/form4-01062026_080121.xml","form_type":"4"}},{"id":945556,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-01-07T01:00:35.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted share unit (\"RSU\") award. One-fourth (1/4) of the total number of RSUs shall vest on January 2, 2027 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one ordinary share."}],"balance_after":143377,"source":{"system":"sec-edgar","filing":"0001901321-26-000002","document":"form4-01062026_080121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000190132126000002/form4-01062026_080121.xml","form_type":"4"}},{"id":1022801,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-10-06T20:45:13.000Z","date":"2025-10-03","kind":"sale","planned":false,"acquired":false,"shares":978,"price":8.41,"value":8224.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.40 to $8.50 inclusive."}],"balance_after":93377,"source":{"system":"sec-edgar","filing":"0001901321-25-000003","document":"form4-10062025_041008.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000190132125000003/form4-10062025_041008.xml","form_type":"4"}},{"id":1022800,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-10-06T20:45:13.000Z","date":"2025-10-02","kind":"sale","planned":false,"acquired":false,"shares":1147,"price":8.4,"value":9634.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.31 to $8.45 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3)."}],"balance_after":94355,"source":{"system":"sec-edgar","filing":"0001901321-25-000003","document":"form4-10062025_041008.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000190132125000003/form4-10062025_041008.xml","form_type":"4"}},{"id":1091062,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-07-07T21:20:11.000Z","date":"2025-07-03","kind":"sale","planned":false,"acquired":false,"shares":966,"price":7.44,"value":7187.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.405 to $7.44 inclusive."}],"balance_after":95502,"source":{"system":"sec-edgar","filing":"0001415889-25-019426","document":"form4-07072025_050706.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588925019426/form4-07072025_050706.xml","form_type":"4"}},{"id":1091061,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-07-07T21:20:11.000Z","date":"2025-07-02","kind":"sale","planned":false,"acquired":false,"shares":1149,"price":7.09,"value":8146.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.09 to $7.14 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3)."}],"balance_after":96468,"source":{"system":"sec-edgar","filing":"0001415889-25-019426","document":"form4-07072025_050706.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588925019426/form4-07072025_050706.xml","form_type":"4"}},{"id":1100014,"issuer":{"id":7510,"kind":"organization","name":"FEMASYS INC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-27T21:25:27.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":17600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option vest one year from the date of grant, assuming continued service."}],"balance_after":17600,"derivative":{"exercise_price":0.98,"expiration_date":"2035-06-25","underlying":"Common Stock","underlying_shares":17600},"source":{"system":"sec-edgar","filing":"0001140361-25-024008","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339005/000114036125024008/form4.xml","form_type":"4"}},{"id":1177346,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-04-04T21:35:08.000Z","date":"2025-04-03","kind":"sale","planned":false,"acquired":false,"shares":1038,"price":7.48,"value":7764.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.43 to $7.50 inclusive."}],"balance_after":97617,"source":{"system":"sec-edgar","filing":"0001415889-25-010242","document":"form4-04042025_050405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588925010242/form4-04042025_050405.xml","form_type":"4"}},{"id":1177345,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-04-04T21:35:08.000Z","date":"2025-04-02","kind":"sale","planned":false,"acquired":false,"shares":1133,"price":8.02,"value":9086.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.12 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3)."}],"balance_after":98655,"source":{"system":"sec-edgar","filing":"0001415889-25-010242","document":"form4-04042025_050405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588925010242/form4-04042025_050405.xml","form_type":"4"}},{"id":1309584,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-07T00:30:26.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":87000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option shall vest with respect to one-fourth (1/4) of the total number of shares underlying the option on January 2, 2026 and the remaining shares in 36 equal monthly installments thereafter."}],"balance_after":87000,"derivative":{"exercise_price":14,"expiration_date":"2035-01-02","underlying":"Ordinary Shares","underlying_shares":87000},"source":{"system":"sec-edgar","filing":"0001415889-25-000924","document":"form4-01062025_070119.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588925000924/form4-01062025_070119.xml","form_type":"4"}},{"id":1309583,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-01-07T00:30:26.000Z","date":"2025-01-03","kind":"sale","planned":false,"acquired":false,"shares":936,"price":14.75,"value":13806.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.60 to $14.75 inclusive."}],"balance_after":99788,"source":{"system":"sec-edgar","filing":"0001415889-25-000924","document":"form4-01062025_070119.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588925000924/form4-01062025_070119.xml","form_type":"4"}},{"id":1309582,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-01-07T00:30:26.000Z","date":"2025-01-02","kind":"sale","planned":false,"acquired":false,"shares":4578,"price":14.09,"value":64504.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.90 to $14.15 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) and (5)."}],"balance_after":100724,"source":{"system":"sec-edgar","filing":"0001415889-25-000924","document":"form4-01062025_070119.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588925000924/form4-01062025_070119.xml","form_type":"4"}},{"id":1309581,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-01-07T00:30:26.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. One-fourth (1/4) of the total number of RSUs shall vest on January 2, 2026 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one ordinary share."}],"balance_after":105302,"source":{"system":"sec-edgar","filing":"0001415889-25-000924","document":"form4-01062025_070119.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588925000924/form4-01062025_070119.xml","form_type":"4"}},{"id":1390595,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-10-04T20:50:10.000Z","date":"2024-10-03","kind":"sale","planned":false,"acquired":false,"shares":972,"price":22.26,"value":21636.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.91 to $22.56 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":70302,"source":{"system":"sec-edgar","filing":"0001415889-24-024769","document":"form4-10042024_041006.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588924024769/form4-10042024_041006.xml","form_type":"4"}},{"id":1454459,"issuer":{"id":7510,"kind":"organization","name":"FEMASYS INC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-15T20:34:50.000Z","date":"2024-07-12","kind":"grant","planned":false,"acquired":true,"shares":17600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option vest one year from the date of grant, assuming continued service."}],"balance_after":17600,"derivative":{"exercise_price":1.14,"expiration_date":"2034-07-12","underlying":"Common Stock","underlying_shares":17600},"source":{"system":"sec-edgar","filing":"0001140361-24-033178","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339005/000114036124033178/form4.xml","form_type":"4"}},{"id":1458105,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-07-08T22:55:04.000Z","date":"2024-07-03","kind":"sale","planned":false,"acquired":false,"shares":967,"price":19.64,"value":18991.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.63 to $19.69 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":71274,"source":{"system":"sec-edgar","filing":"0001415889-24-019383","document":"form4-07082024_060701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588924019383/form4-07082024_060701.xml","form_type":"4"}},{"id":1546387,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-04-05T20:30:40.000Z","date":"2024-04-03","kind":"sale","planned":false,"acquired":false,"shares":955,"price":23.81,"value":22738.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.75 to $24.05 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":72241,"source":{"system":"sec-edgar","filing":"0001415889-24-010416","document":"form4-04052024_040434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588924010416/form4-04052024_040434.xml","form_type":"4"}},{"id":1686834,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-01-04T23:27:13.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":77000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option shall vest one-fourth (1/4) of the total number of shares underlying the option on January 2, 2025 and the remaining shares in 36 equal monthly installments thereafter."}],"balance_after":77000,"derivative":{"exercise_price":18.08,"expiration_date":"2034-01-02","underlying":"Ordinary Shares","underlying_shares":77000},"source":{"system":"sec-edgar","filing":"0001209191-24-000877","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000120919124000877/doc4.xml","form_type":"4"}},{"id":1686833,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2024-01-04T23:27:13.000Z","date":"2024-01-03","kind":"sale","planned":false,"acquired":false,"shares":2643,"price":17.5,"value":46252.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.07 to $18.02 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":73196,"source":{"system":"sec-edgar","filing":"0001209191-24-000877","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000120919124000877/doc4.xml","form_type":"4"}},{"id":1686832,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2024-01-04T23:27:13.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":39000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. One-fourth (1/4) of the total number of RSUs shall vest on January 2, 2025 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one ordinary share."}],"balance_after":75839,"source":{"system":"sec-edgar","filing":"0001209191-24-000877","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000120919124000877/doc4.xml","form_type":"4"}},{"id":1764183,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2023-10-05T21:47:31.000Z","date":"2023-10-03","kind":"sale","planned":false,"acquired":false,"shares":442,"price":20,"value":8840.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.91 to $20.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":36839,"source":{"system":"sec-edgar","filing":"0001209191-23-052251","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000120919123052251/doc4.xml","form_type":"4"}},{"id":1833449,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2023-07-06T20:52:20.000Z","date":"2023-07-03","kind":"sale","planned":false,"acquired":false,"shares":451,"price":25.1,"value":11320.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.85 to $25.69 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":37281,"source":{"system":"sec-edgar","filing":"0001209191-23-041573","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000120919123041573/doc4.xml","form_type":"4"}},{"id":1851662,"issuer":{"id":7510,"kind":"organization","name":"FEMASYS INC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T20:42:46.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in annual one-third (1/3) increments over a three (3) year period beginning on June 14, 2024, assuming continued service."}],"balance_after":17000,"derivative":{"exercise_price":0.64,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001140361-23-030284","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339005/000114036123030284/form4.xml","form_type":"4"}},{"id":1924483,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2023-04-05T20:42:08.000Z","date":"2023-04-03","kind":"sale","planned":false,"acquired":false,"shares":447,"price":21.11,"value":9436.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.03 to $21.15 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":37732,"source":{"system":"sec-edgar","filing":"0001209191-23-023349","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000120919123023349/doc4.xml","form_type":"4"}},{"id":2061595,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-06T02:19:27.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option shall vest one-fourth (1/4) of the total number of shares underlying the option on January 3, 2024 and the remaining shares in 36 equal monthly installments thereafter."}],"balance_after":35000,"derivative":{"exercise_price":29.6,"expiration_date":"2033-01-03","underlying":"Ordinary Shares","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-23-002205","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000120919123002205/doc4.xml","form_type":"4"}},{"id":2061594,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2023-01-06T02:19:27.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":1801,"price":29.06,"value":52337.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to\n$29.545 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and\nExchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in\nthis footnote."}],"balance_after":38179,"source":{"system":"sec-edgar","filing":"0001209191-23-002205","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000120919123002205/doc4.xml","form_type":"4"}},{"id":2061593,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2023-01-06T02:19:27.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. One-fourth (1/4) of the total number of RSUs shall vest on January 3, 2024 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one ordinary share."}],"balance_after":39980,"source":{"system":"sec-edgar","filing":"0001209191-23-002205","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000120919123002205/doc4.xml","form_type":"4"}},{"id":2314795,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-03-29T20:36:19.000Z","date":"2022-03-25","kind":"exercise","acquired":true,"shares":5155,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vested one-fourth (1/4) of the total number of shares underlying the option on January 4, 2022 and the remaining shares in 36 equal monthly installments thereafter."}],"balance_after":46845,"derivative":{"exercise_price":20.12,"expiration_date":"2031-01-12","underlying":"Ordinary Shares","underlying_shares":5155},"source":{"system":"sec-edgar","filing":"0001209191-22-021491","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000120919122021491/doc4.xml","form_type":"4"}},{"id":2314794,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2022-03-29T20:36:19.000Z","date":"2022-03-25","kind":"exercise","acquired":true,"shares":5155,"price":20.12,"value":103718.6,"ownership":{"direct":true},"balance_after":22480,"source":{"system":"sec-edgar","filing":"0001209191-22-021491","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000120919122021491/doc4.xml","form_type":"4"}},{"id":2442572,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-01-05T22:15:22.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option shall vest one-fourth (1/4) of the total number of shares underlying the option on January 3, 2023 and the remaining shares in 36 equal monthly installments thereafter."}],"balance_after":100000,"derivative":{"exercise_price":60.87,"expiration_date":"2032-01-03","underlying":"Ordinary Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-22-001799","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000120919122001799/doc4.xml","form_type":"4"}},{"id":2442571,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":24535,"kind":"person","name":"Milnes Alistair","position":1,"cik":"0001901321","reported_name":"Milnes Alistair","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2022-01-05T22:15:22.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award.  One-fourth (1/4) of the total number of RSUs shall vest on January 3, 2023 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one ordinary share."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001209191-22-001799","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000120919122001799/doc4.xml","form_type":"4"}}]}